To determine the effects of ChPL on MAPK signaling in breast cancer cells, MDA-MB-468 and MCF-7 cells were treated with ChPL and Western blot analysis was performed to examine the effects of ChPL on levels of phosphorylated MEK and ERK in breast cancer cells. This evidence concerns the gene MAP2K7 and breast cancer.